Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies.

Calisti, Fabrizio; Cattaneo, Agnese; Calabrese, Mariangela; Mao, Yongcai; Tocco, Michael; Pikalov, Andrei; Goldman, Robert

Calisti, Fabrizio; Cattaneo, Agnese; Calabrese, Mariangela; Mao, Yongcai; Tocco, Michael; Pikalov, Andrei; Goldman, Robert.

Affiliation

Calisti F; Angelini RR&D (Regulatory, Research, & Development), Angelini Pharma S.p.A., Viale Amelia, Rome, Italy.
Cattaneo A; Angelini RR&D (Regulatory, Research, & Development), Angelini Pharma S.p.A., Viale Amelia, Rome, Italy.
Calabrese M; Angelini RR&D (Regulatory, Research, & Development), Angelini Pharma S.p.A., Viale Amelia, Rome, Italy.
Mao Y; Sunovion Pharmaceuticals Inc, Fort Lee, NJ, and Marlborough, Massachusetts, USA.
Tocco M; Sunovion Pharmaceuticals Inc, Fort Lee, NJ, and Marlborough, Massachusetts, USA.
Pikalov A; Sunovion Pharmaceuticals Inc, Fort Lee, NJ, and Marlborough, Massachusetts, USA.
Goldman R; Sunovion Pharmaceuticals Inc, Fort Lee, NJ, and Marlborough, Massachusetts, USA.

Int Clin Psychopharmacol ; 37(5): 215-222, 2022 09 01.

Article de En | MEDLINE | ID: mdl-35276716

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Schizophrénie / Neuroleptiques Type d'étude: Clinical_trials / Diagnostic_studies Limites: Humans Langue: En Journal: Int Clin Psychopharmacol Sujet du journal: PSICOFARMACOLOGIA Année: 2022 Type de document: Article Pays d'affiliation: Italie Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google